Literature DB >> 1868443

Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin.

V de Franciscis1, R Rosati, G L Colucci-D'Amato, A Eva, G Vecchio.   

Abstract

We have investigated the expression of the dbl protooncogene in a wide variety of human tumors of different embryological derivation. We found that proto-dbl mRNA could be detected preferentially in a few neoplastic histiotypes of neuroectodermal origin. The common, normal 5-kilobase size of the proto-dbl transcript detected indicated that the proto-dbl in these tumors was not rearranged. These data, in agreement with our previous reports, suggest that the dbl protooncogene is expressed in a highly tissue-specific manner and indicate that this gene may be involved in the growth and differentiation of some cells of neuroectodermal origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868443

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line.

Authors:  P E Harris; A I Colovai; A Maffei; Z Liu; N S Foca
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

2.  High frequency of development of B cell lymphoproliferation and diffuse large B cell lymphoma in Dbl knock-in mice.

Authors:  Marzia Ognibene; Ottavia Barbieri; Cristina Vanni; Luca Mastracci; Simonetta Astigiano; Laura Emionite; Barbara Salani; Manuela Fedele; Roberta Resaz; Claudya Tenca; Franco Fais; Federica Sabatini; Amleto De Santanna; Fiorella Altruda; Luigi Varesio; Emilio Hirsch; Alessandra Eva
Journal:  J Mol Med (Berl)       Date:  2011-01-11       Impact factor: 4.599

3.  Defective dendrite elongation but normal fertility in mice lacking the Rho-like GTPase activator Dbl.

Authors:  Emilio Hirsch; Michela Pozzato; Alessandro Vercelli; Laura Barberis; Ornella Azzolino; Chiara Russo; Cristina Vanni; Lorenzo Silengo; Alessandra Eva; Fiorella Altruda
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine.

Authors:  Salvatore Turano; Candida Mastroianni; Caterina Manfredi; Rosalbino Biamonte; Silvia Ceniti; Virginia Liguori; Rosanna De Simone; Serafino Conforti; Aldo Filice; Antonio Rovito; Caterina Viscomi; Giuseppe Patitucci; Salvatore Palazzo
Journal:  J Neurooncol       Date:  2009-11-19       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.